Edgewell个人护理 EPC 深 沪
已收盘 07-02 16:00:00 美东时间
27.21
-0.300
-1.09%
华盛通- 最 高28.009
- 今 开27.61
- 成交量 79.86万股
- 最 低 27.04
- 昨 收 27.51
- 总市值 12.54亿
- 52周最高 28.009
- 市盈率 静 50.99
- 换手率 1.73%
- 52周最低 15.575
- 委 比 0.00%
- 总股本 4608.13万
- 历史最高 107.29
- 量 比 0.63
- 振 幅 3.52%
- 历史最低 15.575
- 每 手 1
- 风险率 2.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Edgewell Personal Care Releases its 2025 Sustainability Report
The Company Discloses its Progress from the 2025 Fiscal Year Across its Business and Functions SHELTON, Conn., June 30, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) has re...
07-01 03:31
美股牛股 | 特朗普政府加码量子计算！QNT涨超13%；Backblaze涨超43%，与CoreWeave签署一项3.35亿美元协议
特朗普政府加码量子计算！ARQQ大涨超35%，QNT涨超13%；Backblaze涨超43%，与CoreWeave签署一项3.35亿美元的数据存储协议>>
06-24 15:51
Why Tianci International Shares Are Trading Higher By Around 88%; Here Are 20 Stocks Moving Premarket
Shares of Tianci International Inc (NASDAQ:CIIT) rose sharply in pre-market trading after the company posted results for the third quarter. The company posted third-quarter earnings of 1 cent per share, versus a year-ago loss of 43 cents per share. Sales rose to $4.311 million from $1.948 million in...
06-23 17:22
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
UBS Maintains Neutral on Edgewell Personal Care, Raises Price Target to $23
UBS analyst Peter Grom maintains Edgewell Personal Care (NYSE:EPC) with a Neutral and raises the price target from $21 to $23.
05-09 06:13
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Transcript: Edgewell Personal Care Q2 2026 Earnings Conference Call
Edgewell Personal Care (NYSE:EPC) reported second-quarter financial results on ...
05-06 20:59
Edgewell Personal Care Q2 Adj. EPS $0.60 Beats $0.45 Estimate, Sales $519.500M Beat $515.046M Estimate
Edgewell Personal Care (NYSE:EPC) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.45 by 33.33 percent. This is a 31.03 percent decrease over earnings of $0.87 per share from
05-06 18:19
8 Stocks to Buy as Merger-Mania Takes Over
Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, semiconductors, medical devices, and media.
03-11 00:42
